Blumberg Capital visit at Bina

It was our pleasure to host Blumberg Capital, which focuses on early and growth-stage investments, particularly in AI and transformative technologies. Our discussions focused on collaborative ways to advance technology, science, and innovation.

We look forward to continuing our dialogue.

More News

ABC Chat with Eyal Ben Ami - M Ventures

As part of Bina’s ABC meetings, we hosted Dr. Eyal Ben Ami, Associate - Science Lead at M Ventures, the corporate venture capital arm of Merck.
M Ventures invests in early-stage biotech and health-tech companies, sitting right at the intersection of cutting-edge science and global industry.
Eyal took us on a journey from the lab bench to the investor’s chair - from academic research in neuroimmunology, through roles in drug development companies and biotech startups, to his current position as an investor in a corporate VC fund.

Bina event - Innovation in AgTech: Challenges & Opportunities

At Bina, we bridge Weizmann Institute of Science’s pioneering research with pressing global challenges and unmet industry needs.

Dr. Reut Mashiach brought that focus to AgTech - addressing food security, climate resilience, and sustainability.

The Jerusalem Press Club (JPC) visit at Bina

It was a pleasure to host The Jerusalem Press Club (JPC) at Bina, the Weizmann Institute of Science.